| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |